MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting

SIMPLE SUMMARY: Lung cancer has a high incidence and affects both men and women. Targeted therapy options directed at certain mutant proteins, and which avoid systemic chemotherapy are already available and emerging. The gene mesenchymal epithelial transition (MET), encoding a receptor tyrosine kina...

Descripción completa

Detalles Bibliográficos
Autores principales: Schubart, Christoph, Stöhr, Robert, Tögel, Lars, Fuchs, Florian, Sirbu, Horia, Seitz, Gerhard, Seggewiss-Bernhardt, Ruth, Leistner, Rumo, Sterlacci, William, Vieth, Michael, Seidl, Christoph, Mugler, Michael, Kapp, Markus, Hohenforst-Schmidt, Wolfgang, Hartmann, Arndt, Haller, Florian, Erber, Ramona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508248/
https://www.ncbi.nlm.nih.gov/pubmed/34638507
http://dx.doi.org/10.3390/cancers13195023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508248/
https://www.ncbi.nlm.nih.gov/pubmed/34638507
http://dx.doi.org/10.3390/cancers13195023

Ejemplares similares